ReWalk Robotics Ltd. provides financial guidance for the second quarter and full year of 2024. For the second quarter, the company expects sequential improvement in revenue as a result of the expanded access to ReWalk systems from the finalized Medicare reimbursement and the improving sales traction of the new commercial team.

For the full year, following the results of first quarter 2024, the company continues to expect revenue of between $28 to $32 million.